naion glp-1 Semaglutide Doesn't Increase Risk in General Population, Study Shows NAION Risks with GLP-1 Medications

Because Sermorelin promotes the natural production of growth hormone rather than synthetically replacing it, the risk of side effects or overdose is exceptionally low

ALA for DPN Oxidative stress is believed to play a focal role in the manifestation of DPN, yet the pathogenesis is complex and remains unclear

Chronic GLP-1 receptor activation by exendin-4 induces expansion of pancreatic duct glands in rats and accelerates formation of dysplastic lesions and chronic pancreatitis in the kras(G12D) mouse model

However, liraglutide achieved this primarily through a pronounced reduction in palatable food intake, whereas sibutramine reduced consumption of both chow and palatable foods (Hansen et al., 2012)

Risks include hypoglycemia, insulin resistance, fluid retention, and potential mitogenic effects , especially with long-term use